Market Cap: $150.45M
CI
Corbus Pharmaceuticals Holdings, Inc.
CRBP
NASDAQUSD
Market Cap: $150.45M
Analysts estimated CRBP earnings of $-1.28 per share this quarter (Q2). CRBP's actual earnings were $-1.81 per share.
CRBP EPS surprise of -41.05%Analysts estimated CRBP earnings of $-1.61 per share this quarter (Q4). CRBP's actual earnings were $-1.25 per share.
CRBP EPS surprise of 22.24%Analysts estimated CRBP earnings of $-1.74 per share this quarter (Q3). CRBP's actual earnings were $-1.90 per share.
CRBP EPS surprise of -9.11%Analysts estimated CRBP earnings of $-1.54 per share this quarter (Q2). CRBP's actual earnings were $-1.44 per share.
CRBP EPS surprise of 6.63%Analysts estimated CRBP earnings of $-1.31 per share this quarter (Q1). CRBP's actual earnings were $-1.39 per share.
CRBP EPS surprise of -6.46%Analysts estimated CRBP earnings of $-1.29 per share this quarter (Q4). CRBP's actual earnings were $-0.78 per share.
CRBP EPS surprise of 39.57%Analysts estimated CRBP earnings of $-0.97 per share this quarter (Q3). CRBP's actual earnings were $-1.15 per share.
CRBP EPS surprise of -18.43%Analysts estimated CRBP earnings of $-1.21 per share this quarter (Q2). CRBP's actual earnings were $-0.90 per share.
CRBP EPS surprise of 25.73%Analysts estimated CRBP earnings of $-1.11 per share this quarter (Q1). CRBP's actual earnings were $-0.83 per share.
CRBP EPS surprise of 25.35%Analysts estimated CRBP earnings of $-2.41 per share this quarter (Q4). CRBP's actual earnings were $-1.81 per share.
CRBP EPS surprise of -24.81%Analysts estimated CRBP earnings of $-2.10 per share this quarter (Q3). CRBP's actual earnings were $-2.05 per share.
CRBP EPS surprise of -2.44%Analysts estimated CRBP earnings of $-2.10 per share this quarter (Q3). CRBP's actual earnings were $-2.05 per share.
CRBP EPS surprise of -2.44%